Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Myovant Sciences (MYOV) Short Interest Ratio & Short Volume

Myovant Sciences logo

Myovant Sciences Short Interest Data

Myovant Sciences (MYOV) has a short interest of 8.39 million shares, representing 16.78% of the float (the number of shares available for trading by the public). This marks a 3.45% increase in short interest from the previous month. The short interest ratio (days to cover) is 8.4, indicating that it would take 8.4 days of the average trading volume of 1.17 million shares to cover all short positions.

Current Short Interest
8,390,000 shares
Previous Short Interest
8,110,000 shares
Change Vs. Previous Month
+3.45%
Dollar Volume Sold Short
$226.19 million
Short Interest Ratio
8.4 Days to Cover
Last Record Date
February 28, 2023
Outstanding Shares
97,240,000 shares
Float Size
50,000,000 shares
Short Percent of Float
16.78%
Today's Trading Volume
2,256,078 shares
Average Trading Volume
1,169,678 shares
Today's Volume Vs. Average
193%
Short Selling Myovant Sciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Myovant Sciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

MYOV Short Interest Over Time

MYOV Days to Cover Over Time

MYOV Percentage of Float Shorted Over Time

Myovant Sciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/28/20238,390,000 shares $226.19 million +3.5%16.8%8.4 $26.96
2/15/20238,110,000 shares $218.56 million +20.3%17.7%10 $26.95
1/31/20236,740,000 shares $181.17 million +4.8%14.7%7.6 $26.88
1/15/20236,430,000 shares $172.97 million +110.8%14.8%3.9 $26.90
12/30/20223,050,000 shares $82.23 million +29.8%7.0%1.9 $26.96
12/15/20222,350,000 shares $62.98 million +16.9%5.4%1.4 $26.80
11/30/20222,010,000 shares $53.99 million -2.9%4.6%1.2 $26.86
11/15/20222,070,000 shares $55.33 million +18.3%4.8%1.2 $26.73
10/31/20221,750,000 shares $46.80 million -43.9%4.1%1 $26.74
10/15/20223,120,000 shares $76.44 million -14.3%7.3%2.2 $24.50
9/30/20223,640,000 shares $65.37 million +10.6%8.5%3.9 $17.96
9/15/20223,290,000 shares $64.29 million -0.3%7.7%4.4 $19.54
8/31/20223,300,000 shares $56.40 million +10.0%7.8%4.2 $17.09
8/15/20223,000,000 shares $55.20 million +2.0%7.1%4.1 $18.40
7/31/20222,940,000 shares $38.46 million -3.9%6.9%3.6 $13.08
7/15/20223,060,000 shares $39.23 million -18.6%7.3%4 $12.82
6/30/20223,760,000 shares $46.74 million -13.2%8.9%4.3 $12.43
6/15/20224,330,000 shares $47.33 million -7.5%10.3%5 $10.93
5/31/20224,680,000 shares $48.53 million -6.6%11.3%5.8 $10.37
5/15/20225,010,000 shares $46.19 million +12.8%12.1%6.1 $9.22
4/30/20224,440,000 shares $41.34 million -0.2%10.9%5.8 $9.31
4/15/20224,450,000 shares $50.42 million +1.4%11.0%5.7 $11.33
3/31/20224,390,000 shares $58.47 million +4.3%10.7%6.2 $13.32
3/15/20224,210,000 shares $50.60 million -1.2%10.2%5.7 $12.02
2/28/20224,260,000 shares $57.17 million -0.2%10.4%5.4 $13.42
2/15/20224,270,000 shares $59.69 million -5.3%10.4%5.1 $13.98
1/31/20224,510,000 shares $58.90 million -12.4%11.0%5.9 $13.06
1/15/20225,150,000 shares $79.05 million +5.8%12.7%6.7 $15.35
12/31/20214,870,000 shares $75.83 million -1.6%12.0%7.5 $15.57
12/15/20214,950,000 shares $75.14 million +31.3%12.2%7.9 $15.18
11/30/20213,770,000 shares $63.37 million -5.5%9.3%5.9 $16.81
11/15/20213,990,000 shares $84.47 million -3.4%9.8%7 $21.17
10/29/20214,130,000 shares $90.36 million +4.3%10.4%6.9 $21.88
10/15/20213,960,000 shares $82.37 million -4.6%10.1%6.1 $20.80
9/30/20214,150,000 shares $93.13 million +4.5%10.6%6.2 $22.44
9/15/20213,970,000 shares $86.67 million -8.7%10.1%5.9 $21.83
8/31/20214,350,000 shares $105.88 million -14.7%10.9%6.2 $24.34
8/13/20215,100,000 shares $109.75 million +3.5%12.6%7 $21.52
7/30/20214,930,000 shares $101.16 million +24.8%12.3%6.4 $20.52
7/15/20213,950,000 shares $75.88 million -26.4%11.0%5.5 $19.21
Elon Warns “America Is Broke”. Trump’s Plan Inside. (Ad)

Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history. Now, he's sounding the alarm about America's $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are...

6/30/20215,370,000 shares $122.27 million +32.6%14.9%7.3 $22.77
6/15/20214,050,000 shares $84.24 million +33.7%12.4%5 $20.80
5/28/20213,030,000 shares $70.99 million -1.0%9.3%3.9 $23.43
5/14/20213,060,000 shares $62.39 million -16.9%9.6%4 $20.39
4/30/20213,680,000 shares $76.03 million -0.8%11.6%4.6 $20.66
4/15/20213,710,000 shares $65.07 million -18.1%11.7%4.2 $17.54
3/31/20214,530,000 shares $92.68 million +30.6%14.2%4.8 $20.46
3/15/20213,470,000 shares $81.51 million -13.7%10.8%3 $23.49
2/26/20214,020,000 shares $87.44 million +32.2%12.6%3.6 $21.75
2/12/20213,040,000 shares $67.03 million +12.2%9.5%2.7 $22.05
1/29/20212,710,000 shares $66.10 million -4.6%8.5%2.4 $24.39
1/15/20212,840,000 shares $60.95 million +6.8%8.9%2.6 $21.46
12/31/20202,660,000 shares $73.26 million -4.0%8.3%2.6 $27.54
12/15/20202,770,000 shares $66.78 million -5.5%8.6%2.3 $24.11
11/30/20202,930,000 shares $68.94 million -28.2%9.1%2.6 $23.53
11/15/20204,080,000 shares $80.62 million +6.0%12.8%3.6 $19.76
10/30/20203,850,000 shares $57.29 million -10.9%12.1%3.4 $14.88
10/15/20204,320,000 shares $68.82 million +116.0%13.6%3.7 $15.93
9/30/20202,000,000 shares $28.10 million +8.7%6.3%1.7 $14.05
9/15/20201,840,000 shares $39.50 million +14.3%5.8%2.2 $21.47
8/31/20201,610,000 shares $32.81 million -8.5%5.1%1.7 $20.38
8/14/20201,760,000 shares $29.74 million -13.3%5.6%1.4 $16.90
7/31/20202,030,000 shares $30.86 million -2.4%6.4%1.6 $15.20
7/15/20202,080,000 shares $37.29 million -15.8%6.7%1.6 $17.93
6/30/20202,470,000 shares $50.93 million -17.9%7.9%1.9 $20.62
6/15/20203,010,000 shares $51.11 million -0.3%9.6%2.2 $16.98
5/29/20203,020,000 shares $37.00 million -5.3%9.7%2.5 $12.25
5/15/20203,190,000 shares $38.98 million +5.6%10.2%3.7 $12.22

MYOV Short Interest - Frequently Asked Questions

What is Myovant Sciences' current short interest?

Short interest is the volume of Myovant Sciences shares that have been sold short but have not yet been covered or closed out. As of February 28th, investors have sold 8,390,000 shares of MYOV short. 16.78% of Myovant Sciences' shares are currently sold short. Learn More on Myovant Sciences' current short interest.

What is a good short interest ratio for Myovant Sciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MYOV shares currently have a short interest ratio of 8.0. Learn More on Myovant Sciences's short interest ratio.

What is a good short interest percentage for Myovant Sciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.78% of Myovant Sciences' floating shares are currently sold short.

Is Myovant Sciences' short interest increasing or decreasing?

Myovant Sciences saw a increase in short interest in the month of February. As of February 28th, there was short interest totaling 8,390,000 shares, an increase of 3.5% from the previous total of 8,110,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Myovant Sciences' float size?

Myovant Sciences currently has issued a total of 97,240,000 shares. Some of Myovant Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Myovant Sciences currently has a public float of 50,000,000 shares.

How does Myovant Sciences' short interest compare to its competitors?

16.78% of Myovant Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Myovant Sciences: Ascendis Pharma A/S (11.37%), Viatris Inc. (3.96%), Roivant Sciences Ltd. (11.68%), Corcept Therapeutics Incorporated (13.18%), Jazz Pharmaceuticals plc (7.81%), BridgeBio Pharma, Inc. (15.57%), Madrigal Pharmaceuticals, Inc. (23.94%), Blueprint Medicines Co. (9.08%), Sarepta Therapeutics, Inc. (7.51%), Legend Biotech Co. (5.49%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Suncor Energy Inc. ($3.27 billion), Occidental Petroleum Co. ($2.77 billion), Coinbase Global, Inc. ($2.25 billion), T. Rowe Price Group, Inc. ($2.23 billion), Paramount Global ($1.92 billion), Etsy, Inc. ($1.75 billion), Voya Financial, Inc. ($1.74 billion), CarMax, Inc. ($1.62 billion), Old Dominion Freight Line, Inc. ($1.62 billion), and Royal Caribbean Cruises Ltd. ($1.39 billion). View all of the most shorted stocks.

What does it mean to sell short Myovant Sciences stock?

Short selling MYOV is an investing strategy that aims to generate trading profit from Myovant Sciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Myovant Sciences?

A short squeeze for Myovant Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MYOV, which in turn drives the price of the stock up even further.

How often is Myovant Sciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MYOV, twice per month. The most recent reporting period available is February, 28 2023.




This page (NYSE:MYOV) was last updated on 5/11/2025 by MarketBeat.com Staff
From Our Partners